Trials / Completed
CompletedNCT03727347
Posterior Nasal Nerve (PNN) Rhinitis Study
Clinical Evaluation of Low Power Radiofrequency Energy Applied to the Posterior Nasal Nerve Area for Symptomatic Relief of Chronic Rhinitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Aerin Medical · Industry
- Sex
- All
- Age
- 22 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Evaluation of the Aerin Medical Device used for the treatment of chronic rhinitis
Detailed description
This is a non-significant risk, prospective, multi-center, non-randomized study to evaluate the safety and efficacy of the Aerin Medical device (InSeca Stylus) when used to deliver radiofrequency (RF) energy to the posterior nasal nerve area to improve symptoms in those diagnosed with chronic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | InSeca Stylus | Low power radiofrequency energy delivery to the portion of the nasal cavity mucosa overlying the region of the posterior nasal nerve (the posterior middle meatus and posterior inferior meatus). |
Timeline
- Start date
- 2018-10-16
- Primary completion
- 2020-02-01
- Completion
- 2020-09-17
- First posted
- 2018-11-01
- Last updated
- 2021-06-16
- Results posted
- 2021-06-16
Locations
5 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03727347. Inclusion in this directory is not an endorsement.